The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
Today we're joined by Ivan Kairatov, a biopharma expert with a deep understanding of the technological innovations driving the industry, particularly in oncology. His work at the intersection of research and development gives him a unique perspective on the recent FDA clearance for PharmaResearch’s
Medical diagnostics often present a difficult choice between speed, detail, and safety, forcing clinicians to navigate a complex landscape of imaging technologies, each with its own set of compromises. While some methods offer rapid, real-time views, they may lack the resolution needed for a
The staggering reality of cancer in Europe continues to cast a long shadow, with over 3.2 million new diagnoses and 1.5 million lives lost each year, underscoring the urgent need for a unified and effective response. Amid this challenge, a powerful new paradigm in oncology has emerged, encapsulated
A brief but deeply impactful federal government shutdown has thrown crucial healthcare services into disarray, abruptly halting the pandemic-era Medicare telehealth and Hospital-at-Home flexibilities that have become a lifeline for millions of Americans. This funding lapse, triggered by a
The landscape of pediatric dermatology is undergoing a profound transformation, steering away from generalized treatment models toward an era defined by precision medicine and targeted intervention. This significant shift, fueled by advancements in diagnostic precision and the arrival of a new
